Experiments described by Zhang et al. indicate that UA and UAMMC9 bind directly to the catalytic site of SENP1, inhibit its activity at nM concentrations, and overcome ovarian cancer cisplatin resistance [16]. The gene discussed is SENP1; the disease is ovarian carcinoma.